Calendar iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse 21:10:00 26/04/2024 BST 5-day change 1st Jan Change
1.76 USD +2.33% Intraday chart for iBio, Inc. +2.33% +28.47%

Chart calendar iBio, Inc.

94ae3b346311bb8.DrguG1L1DaGxt_6qcQSb2N-sdpS9OsGrsfnptAKlZpQ.S5UeQzmBQ5HJ3KTAR0DwrY2eDuGNQ6Wd27SDxVjCKqNL4nZ8P8dZyPL_qw~704ae852e48a74faa3e86c0ee03bdb56

Upcoming events on iBio, Inc.

09/05/2024 Q3 2024 Earnings Release (Projected)
23/09/2024 Q4 2024 Earnings Release (Projected)

Past events on iBio, Inc.

27/03/2024 12:30 Business Update Call
17/01/2024 01:15 PepTalk Conference
28/11/2023 Reverse Split: 1 of 20
27/11/2023 21:00 Annual General Meeting
12/10/2023 11:20 Biologics Festival - Enhancing Bispecific T Cell Engager Discovery
10/10/2023 13:20 Biologics Festival - Pitfalls to Avoid When Building an AI-Driven Platform Company
27/09/2023 21:19 Q4 2023 Earnings Release
16/05/2023 17:00 JMP Securities Life Sciences Conference - Fireside Chat
07/12/2022 18:20 JMP Securities Hematology and Oncology Summit
03/12/2022 Antibody Engineering & Therapeutics Conference - Epitope-Targeted
03/12/2022 Antibody Engineering & Therapeutics Conference - Fully Human & Developable Antibody
09/10/2022 Reverse Split: 1 of 25
27/09/2022 21:30 FY 2022 Earnings Call
27/09/2022 21:10 FY 2022 Earnings Release
30/06/2022 14:30 Extraordinary Shareholders Meeting
23/05/2022 H.C. Wainwright Global Life Sciences Investment Conference
12/05/2022 21:30 Q3 2022 Earnings Call
12/05/2022 21:05 Q3 2022 Earnings Release
01/05/2022 Protein & Antibody Engineering Summit Boston Conference & Expo
17/03/2022 18:40 Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
2,02


1,64
0,60
173%
2,37
2,60
-8.81%
2,38
2,50
-4.68%
0,39
0,50
-21.8%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-14,0
-15,9
11.93%
-31,1
-29,5
-5.46%
-49,7
-43,2
-15.02%
0,00
0,00
-
Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Net income
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EPS
USD
Released
Forecast
Spread
-470


0,00
0,00
-
0,00
0,00
-
-116
-115
-0.52%
0,00
0,00
-
Announcement Date26/08/1913/10/2027/09/2111/10/2227/09/23

Quarterly results

Fiscal PeriodJuni 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2
Net sales
Million USD
Released
Forecast
Spread
0,17
0,25
-32.8%
1,94
0,20
871.5%
0,06
0,20
-69.5%
0,00
0,60
-
0,13
0,60
-78.33%
0,21
0,20
2.5%
0,00
0,20
-
0,00


EBIT
Million USD
Released
Forecast
Spread
-11,6
-9,56
-21.72%
-12,2
-11,4
-6.86%
-16,9
-12,2
-38.49%
-7,64
-17,9
57.34%
-10,6
-6,80
-55.49%









Net income
Million USD
Released
Forecast
Spread
-11,9
-9,53
-25.34%





















EPS
USD
Released
Forecast
Spread
-25,0
-20,0
-25%
-30,0
-30,0
0%
-113
-40,0
-181.5%
-41,0
-35,0
-17.14%









-4,42


Announcement Date14/02/2212/05/2211/10/2214/11/2214/02/2315/05/2327/09/2315/02/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise